TechCrunch+ roundup: Non-dilutive biotech capital, long-term angel investing, WayRay’s $80M pitch deck
TechCrunch
JUNE 24, 2022
According to Kyle Poyar, a partner at OpenView, the current downturn is creating similar opportunities for SaaS startups. Long-term angel investing: Understanding capital requirements and how to find quality investments. 3 tips for biotech startups seeking non-dilutive capital to weather the downturn.
Let's personalize your content